About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Paltusotine
(D12477)

[1] Paltusotine

[2] Paltusotine (D12477),
Paltusotine hydrochloride 💬

[1] SSTR2 💬

[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 77 💬

2

Paltusotine (Free base)
(D12477)

[1] Paltusotine

[2] Paltusotine (D12477),
Paltusotine hydrochloride 💬

[1] SSTR2 💬

[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 77 💬

3

PaltusotineProduct Code: CRN00808Pharmaceutical Form: TabletINN or Proposed INN: Paltusotine (Free base)CAS Number: 2172870-89-0Current Sponsor code: CRN00808Other descriptive name: PaltusotineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use
(D12477)

[1] Paltusotine

[2] Paltusotine (D12477),
Paltusotine hydrochloride 💬

[1] SSTR2 💬

[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬

[1] 77 💬